Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SGLT2i in Kidney Stones — Stella

Home/Kidney Stones/SGLT2i in Kidney Stones

View on ClinicalTrials.gov

Recruiting

Back to Kidney Stones trials

SGLT2i in Kidney Stones

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

University of Chicago, Chicago, Illinois

Key details

Phase

Very early testing

Sponsor

University of Chicago

Collaborators

National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrollment target

~32 participants

Started

November 2025

Primary completion

November 2027

Age range

18 Years – 70 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.